Cargando…

The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia

BACKGROUND: The study is done in Ayder Referral Hospital in Northern Ethiopia. Ethiopia is one of the countries where visceral leishmaniasis (VL) is endemic. Diagnosis of VL in Ethiopia is primarily based on rK39 immunochromatographic (rk39-ICT) strip. This test has been shown to have variable sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiros, Yazezew Kebede, Regassa, Bethlhem Feleke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407002/
https://www.ncbi.nlm.nih.gov/pubmed/28446246
http://dx.doi.org/10.1186/s13104-017-2490-3
_version_ 1783232078170554368
author Kiros, Yazezew Kebede
Regassa, Bethlhem Feleke
author_facet Kiros, Yazezew Kebede
Regassa, Bethlhem Feleke
author_sort Kiros, Yazezew Kebede
collection PubMed
description BACKGROUND: The study is done in Ayder Referral Hospital in Northern Ethiopia. Ethiopia is one of the countries where visceral leishmaniasis (VL) is endemic. Diagnosis of VL in Ethiopia is primarily based on rK39 immunochromatographic (rk39-ICT) strip. This test has been shown to have variable sensitivity and specificity in different countries. Hence the objective of the study is to determine the sensitivity and specificity of rk39-ICT in the diagnosis of VL in our set up. The study participants were VL suspected patients admitted to the hospital. A cross sectional study design was used. The study was conducted from January 14, 2013 to June 26, 2015. The rK39-ICT strip used was the InBios brand. Ethical clearance was obtained from the IRB of the college and written consent was obtained from the individual patients. RESULTS: A total of 62 VL suspects were involved in the study. The mean age was 26.3 years (SD = 6.94 years) with a median age of 25.5 years. Sixty-one (98.4%) of the patients was males. The rK39-ICT was positive in 50 (80.6%) of the patients. Splenic aspiration was positive in 44 (71%) of the patients. In 37 (59.7%) of the patients both rK39 and splenic aspiration were positive. Thirteen (21%) of the patients had positive rK39 but negative splenic aspiration. Five (8.1%) of the patients had both negative rK39 and splenic aspiration however seven (11.3%) of the patients had rk39 negative but splenic aspiration positive. The sensitivity, specificity, positive predictive value and the negative predictive value of rK39-ICT, taking splenic aspiration as a gold standard test, is 84.1% (95% CI 69.9–93.4%), 27.8% (95% CI 9.7–53.5%), 74.0% (95% CI 60–85.4%) and 41.7% (95% CI 15.2–72.3%) respectively. CONCLUSION: Sensitivity of rK39-ICT is low and its specificity is poor in our set up. Significant number of patients with confirmed VL did not have travel history to endemic areas. We recommend that the rK39-ICT needs improvement for clinical use in our set up and case definition for visceral leishmaniasis in Ethiopia needs to be revisited.
format Online
Article
Text
id pubmed-5407002
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54070022017-05-02 The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia Kiros, Yazezew Kebede Regassa, Bethlhem Feleke BMC Res Notes Research Article BACKGROUND: The study is done in Ayder Referral Hospital in Northern Ethiopia. Ethiopia is one of the countries where visceral leishmaniasis (VL) is endemic. Diagnosis of VL in Ethiopia is primarily based on rK39 immunochromatographic (rk39-ICT) strip. This test has been shown to have variable sensitivity and specificity in different countries. Hence the objective of the study is to determine the sensitivity and specificity of rk39-ICT in the diagnosis of VL in our set up. The study participants were VL suspected patients admitted to the hospital. A cross sectional study design was used. The study was conducted from January 14, 2013 to June 26, 2015. The rK39-ICT strip used was the InBios brand. Ethical clearance was obtained from the IRB of the college and written consent was obtained from the individual patients. RESULTS: A total of 62 VL suspects were involved in the study. The mean age was 26.3 years (SD = 6.94 years) with a median age of 25.5 years. Sixty-one (98.4%) of the patients was males. The rK39-ICT was positive in 50 (80.6%) of the patients. Splenic aspiration was positive in 44 (71%) of the patients. In 37 (59.7%) of the patients both rK39 and splenic aspiration were positive. Thirteen (21%) of the patients had positive rK39 but negative splenic aspiration. Five (8.1%) of the patients had both negative rK39 and splenic aspiration however seven (11.3%) of the patients had rk39 negative but splenic aspiration positive. The sensitivity, specificity, positive predictive value and the negative predictive value of rK39-ICT, taking splenic aspiration as a gold standard test, is 84.1% (95% CI 69.9–93.4%), 27.8% (95% CI 9.7–53.5%), 74.0% (95% CI 60–85.4%) and 41.7% (95% CI 15.2–72.3%) respectively. CONCLUSION: Sensitivity of rK39-ICT is low and its specificity is poor in our set up. Significant number of patients with confirmed VL did not have travel history to endemic areas. We recommend that the rK39-ICT needs improvement for clinical use in our set up and case definition for visceral leishmaniasis in Ethiopia needs to be revisited. BioMed Central 2017-04-26 /pmc/articles/PMC5407002/ /pubmed/28446246 http://dx.doi.org/10.1186/s13104-017-2490-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kiros, Yazezew Kebede
Regassa, Bethlhem Feleke
The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title_full The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title_fullStr The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title_full_unstemmed The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title_short The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia
title_sort role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a tertiary hospital, northern ethiopia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407002/
https://www.ncbi.nlm.nih.gov/pubmed/28446246
http://dx.doi.org/10.1186/s13104-017-2490-3
work_keys_str_mv AT kirosyazezewkebede theroleofrk39serologictestinthediagnosisofvisceralleishmaniasisinatertiaryhospitalnorthernethiopia
AT regassabethlhemfeleke theroleofrk39serologictestinthediagnosisofvisceralleishmaniasisinatertiaryhospitalnorthernethiopia
AT kirosyazezewkebede roleofrk39serologictestinthediagnosisofvisceralleishmaniasisinatertiaryhospitalnorthernethiopia
AT regassabethlhemfeleke roleofrk39serologictestinthediagnosisofvisceralleishmaniasisinatertiaryhospitalnorthernethiopia